S. Balakrishna Pai

This research record centers on how natural compounds and drug candidates affect cancer cells at the molecular level, examining processes like cell death, signaling pathways, and potential drug targets across cancers including colorectal, prostate, esophageal, pancreatic, and glioma. The body of work also includes some unrelated publications spanning infectious disease and engineering education topics, suggesting the name may be associated with multiple distinct research efforts or collaborations rather than a single focused program.

Publication output has been relatively steady but modest over the last decade, averaging about 2 papers per year, with a notable spike in 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026